BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, Sychrová A, Barreca D, Ziberna L, Mahomoodally MF, Zengin G, Xu S, Nabavi SM, Shen AZ. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics 2019;9:1923-51. [PMID: 31037148 DOI: 10.7150/thno.30787] [Cited by in Crossref: 126] [Cited by in F6Publishing: 124] [Article Influence: 42.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Su H, Liu J, Ding Y. Protective Effect of Natural Medicinal Plants on Cardiomyocyte Injury in Heart Failure: Targeting the Dysregulation of Mitochondrial Homeostasis and Mitophagy. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/3617086] [Reference Citation Analysis]
2 Diao J, Chen X, Mou P, Ma X, Wei R. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. Invest Ophthalmol Vis Sci 2022;63:6. [PMID: 36094643 DOI: 10.1167/iovs.63.10.6] [Reference Citation Analysis]
3 Yang Y, Cao S, Xu W, Zang C, Zhang F, Xie Y, Wu C. Dual modulation of gut bacteria and fungi manifests the gut-based anti-hyperlipidemic effect of Coptidis Rhizoma. Biomedicine & Pharmacotherapy 2022;153:113542. [DOI: 10.1016/j.biopha.2022.113542] [Reference Citation Analysis]
4 Koperska A, Wesołek A, Moszak M, Szulińska M. Berberine in Non-Alcoholic Fatty Liver Disease—A Review. Nutrients 2022;14:3459. [DOI: 10.3390/nu14173459] [Reference Citation Analysis]
5 Zhang Y, Guo Y, Wei W, Zhang Z, Xu X. Metabolomics profiling reveals berberine-inhibited inflammatory response in human gingival fibroblasts by regulating the LPS-induced apoptosis signaling pathway. Front Pharmacol 2022;13:940224. [DOI: 10.3389/fphar.2022.940224] [Reference Citation Analysis]
6 Fang X, Wu H, Wei J, Miao R, Zhang Y, Tian J. Research progress on the pharmacological effects of berberine targeting mitochondria. Front Endocrinol 2022;13:982145. [DOI: 10.3389/fendo.2022.982145] [Reference Citation Analysis]
7 Zhong Y, Zeng X, Zeng Y, Yang L, Peng J, Zhao L, Chang Y. Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases. Nano Today 2022;45:101554. [DOI: 10.1016/j.nantod.2022.101554] [Reference Citation Analysis]
8 He H, Deng J, Yang M, An L, Ye X, Li X. Jatrorrhizine from Rhizoma Coptidis exerts an anti-obesity effect in db/db mice. J Ethnopharmacol 2022;:115529. [PMID: 35835345 DOI: 10.1016/j.jep.2022.115529] [Reference Citation Analysis]
9 Yang S, Cao S, Li C, Zhang J, Liu C, Qiu F, Kang N. Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota. Front Pharmacol 2022;13:913378. [DOI: 10.3389/fphar.2022.913378] [Reference Citation Analysis]
10 Yarmohammadi F, Hayes AW, Karimi G. The therapeutic effects of berberine against different diseases: A review on the involvement of the endoplasmic reticulum stress. Phytother Res 2022. [PMID: 35778942 DOI: 10.1002/ptr.7539] [Reference Citation Analysis]
11 Dai L, Zhu L, Ma S, Liu J, Zhang M, Li J, Luo Y, Zhou X, Chen Q, Wang L, Huang Y, Chen Y. Berberine alleviates NLRP3 inflammasome induced endothelial junction dysfunction through Ca2+ signalling in inflammatory vascular injury. Phytomedicine 2022;101:154131. [DOI: 10.1016/j.phymed.2022.154131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lan T, Xu T, Fu Y, Jiang S, Liang X, Yu Z, Pan L, Rong X, Guo J. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis. Front Endocrinol 2022;13:864703. [DOI: 10.3389/fendo.2022.864703] [Reference Citation Analysis]
13 Wang N, Tian Y, Yan F, Zhao F, Wang R, Luo Y, Zheng Y. Berberine protects against chronic cerebral hypoperfusion-induced cognitive impairment and hippocampal damage via regulation of the ERK/Nrf2 pathway. J Chem Neuroanat 2022;123:102119. [PMID: 35697268 DOI: 10.1016/j.jchemneu.2022.102119] [Reference Citation Analysis]
14 Wang Z, Chen P, Guo M, Yang X, Song W, Huang F. Physicochemical Characterization of Berberine-loaded Pluronic F127 Polymeric Micelles and In Vivo Evaluation of Hypoglycemic Effect. J Pharm Innov. [DOI: 10.1007/s12247-022-09658-6] [Reference Citation Analysis]
15 Behl T, Singh S, Sharma N, Zahoor I, Albarrati A, Albratty M, Meraya AM, Najmi A, Bungau S. Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends. Molecules 2022;27:3705. [PMID: 35744831 DOI: 10.3390/molecules27123705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Peng JF, Salami OM, Lei C, Ni D, Habimana O, Yi GH. Targeted mitochondrial drugs for treatment of Myocardial ischemia-reperfusion injury. J Drug Target 2022;:1-21. [PMID: 35652502 DOI: 10.1080/1061186X.2022.2085728] [Reference Citation Analysis]
17 Cheng Z, Kang C, Che S, Su J, Sun Q, Ge T, Guo Y, Lv J, Sun Z, Yang W, Li B, Li X, Cui R. Berberine: A Promising Treatment for Neurodegenerative Diseases. Front Pharmacol 2022;13:845591. [DOI: 10.3389/fphar.2022.845591] [Reference Citation Analysis]
18 Jiang X, Jiang Z, Jiang M, Sun Y. Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Front Med 2022;9:886996. [DOI: 10.3389/fmed.2022.886996] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Vekic J, Zeljkovic A, Stefanovic A, Bogavac-stanojevic N, Ilias I, Silva-nunes J, Stoian AP, Janez A, Rizzo M. Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL. Pharmaceutics 2022;14:825. [DOI: 10.3390/pharmaceutics14040825] [Reference Citation Analysis]
20 Ai X, Yu P, Peng L, Luo L, Liu J, Li S, Lai X, Luan F, Meng X. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases. Front Pharmacol 2021;12:762654. [PMID: 35370628 DOI: 10.3389/fphar.2021.762654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Shekarabi SPH, Mehrgan MS, Ramezani F, Dawood MA, Van Doan H, Moonmanee T, Hamid NKA, Kari ZA. Effect of dietary barberry fruit (Berberis vulgaris) extract on immune function, antioxidant capacity, antibacterial activity, and stress-related gene expression of Siberian sturgeon (Acipenser baerii). Aquaculture Reports 2022;23:101041. [DOI: 10.1016/j.aqrep.2022.101041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Sagada G, Wang L, Xu B, Tegomo FA, Chen K, Zheng L, Sun Y, Liu Y, Yang Y, Ullah S, Shao Q, Dawood M. Synergistic Effect of Dietary Inactivated Lactobacillus plantarum and Berberine Supplementation on Growth Performance, Antioxidant Capacity, and Immune Function of Juvenile Black Sea Bream (Acanthopagrus schlegelii). Aquaculture Nutrition 2022;2022:1-12. [DOI: 10.1155/2022/3053724] [Reference Citation Analysis]
23 Wu C, Yan J, Li W. Acacetin as a Potential Protective Compound against Cardiovascular Diseases. Evid Based Complement Alternat Med 2022;2022:6265198. [PMID: 35280514 DOI: 10.1155/2022/6265198] [Reference Citation Analysis]
24 Yu Q, Li M, Chen H, Xu L, Cheng J, Lin G, Liu Y, Su Z, Yang X, Li Y, Chen J, Xie J. The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics. Drug Delivery 2022;29:856-70. [DOI: 10.1080/10717544.2022.2036870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 An N, Zhang G, Li Y, Yuan C, Yang F, Zhang L, Gao Y, Xing Y. Promising Antioxidative Effect of Berberine in Cardiovascular Diseases. Front Pharmacol 2022;13:865353. [DOI: 10.3389/fphar.2022.865353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Huang Q, He W, Weng Y, Wang Y, Liu Y, Xiang Y, Li X, Jiang P, Jin Y, Luo J, Shi Q. Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1/5/8 and NF-κB pathways. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106986] [Reference Citation Analysis]
27 Zhang S, Jiang M, Yan S, Liang M, Wang W, Yuan B, Xu Q. Network Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive Disorder. Front Pharmacol 2021;12:793012. [PMID: 35185541 DOI: 10.3389/fphar.2021.793012] [Reference Citation Analysis]
28 Zhu Y, Xie N, Chai Y, Nie Y, Liu K, Liu Y, Yang Y, Su J, Zhang C. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Front Pharmacol 2022;13:803717. [PMID: 35153781 DOI: 10.3389/fphar.2022.803717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Liu M, Wu Y. Role of Mitophagy in Coronary Heart Disease: Targeting the Mitochondrial Dysfunction and Inflammatory Regulation. Front Cardiovasc Med 2022;9:819454. [DOI: 10.3389/fcvm.2022.819454] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Mishra N, Verma R, Jadaun P. Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study. Cureus. [DOI: 10.7759/cureus.21781] [Reference Citation Analysis]
31 Heidary Moghaddam R, Samimi Z, Asgary S, Mohammadi P, Hozeifi S, Hoseinzadeh-Chahkandak F, Xu S, Farzaei MH. Natural AMPK Activators in Cardiovascular Disease Prevention. Front Pharmacol 2021;12:738420. [PMID: 35046800 DOI: 10.3389/fphar.2021.738420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Sharma PK, Choudhury D, Yadav V, Murty USN, Banerjee S. 3D printing of nanocomposite pills through desktop vat photopolymerization (stereolithography) for drug delivery reasons. 3D Print Med 2022;8:3. [PMID: 35038049 DOI: 10.1186/s41205-022-00130-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Pu Z, Sun Y, Jiang H, Hou Q, Yan H, Wen H, Li G. Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine. Am J Chin Med 2021;49:1949-63. [PMID: 34961418 DOI: 10.1142/S0192415X21500920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Wei P, Long D, Tan Y, Xing W, Li X, Yang K, Liu H. Integrated Pharmacogenetics Analysis of the Three Fangjis Decoctions for Treating Arrhythmias Based on Molecular Network Patterns. Front Cardiovasc Med 2021;8:726694. [PMID: 35004871 DOI: 10.3389/fcvm.2021.726694] [Reference Citation Analysis]
35 Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Front Pharmacol 2021;12:764994. [PMID: 35002703 DOI: 10.3389/fphar.2021.764994] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
36 Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev 2021;2021:2074610. [PMID: 34956436 DOI: 10.1155/2021/2074610] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
37 Rui R, Yang H, Liu Y, Zhou Y, Xu X, Li C, Liu S. Effects of Berberine on Atherosclerosis. Front Pharmacol 2021;12:764175. [PMID: 34899318 DOI: 10.3389/fphar.2021.764175] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Xue Z, Li Y, Zhou M, Liu Z, Fan G, Wang X, Zhu Y, Yang J. Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension. Front Pharmacol 2021;12:720873. [PMID: 34899290 DOI: 10.3389/fphar.2021.720873] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Xing L, Zhou X, Li AH, Li HJ, He CX, Qin W, Zhao D, Li PQ, Zhu L, Cao HL. Atheroprotective Effects and Molecular Mechanism of Berberine. Front Mol Biosci 2021;8:762673. [PMID: 34869592 DOI: 10.3389/fmolb.2021.762673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Lin G, Yu Q, Xu L, Huang Z, Mai L, Jiang L, Su Z, Xie J, Li Y, Liu Y, Lin Z, Chen J. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. Eur J Pharmacol 2021;912:174592. [PMID: 34699754 DOI: 10.1016/j.ejphar.2021.174592] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
41 Li J, Wang Y, Chen D, Liu-Bryan R. Oral administration of berberine limits post-traumatic osteoarthritis development and associated pain via AMP-activated protein kinase (AMPK) in mice. Osteoarthritis Cartilage 2021:S1063-4584(21)00935-3. [PMID: 34687898 DOI: 10.1016/j.joca.2021.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Cheng CK, Huang Y. The gut-cardiovascular connection: new era for cardiovascular therapy. Medical Review 2021;1:23-46. [DOI: 10.1515/mr-2021-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Sarbadhikary P, George BP, Abrahamse H. Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases. Molecules 2021;26:6238. [PMID: 34684819 DOI: 10.3390/molecules26206238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Fang Y, Wang X, Yang D, Lu Y, Wei G, Yu W, Liu X, Zheng Q, Ying J, Hua F. Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node. Front Aging Neurosci 2021;13:738686. [PMID: 34616289 DOI: 10.3389/fnagi.2021.738686] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
45 Chen Y, Li L, Xu R, Li F, Gu L, Liu H, Wang Z, Yang L. Characterization of natural herbal medicines by thin-layer chromatography combined with laser ablation-assisted direct analysis in real-time mass spectrometry. J Chromatogr A 2021;1654:462461. [PMID: 34438305 DOI: 10.1016/j.chroma.2021.462461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Supruniuk E, Żebrowska E, Chabowski A. Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? Crit Rev Food Sci Nutr 2021;:1-39. [PMID: 34542351 DOI: 10.1080/10408398.2021.1977910] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
47 Wickhorst PJ, Druzhinin SI, Ihmels H, Müller M, Sutera Sardo M, Schönherr H, Viola G. A Dimethylaminophenyl‐Substituted Naphtho[1,2‐ b ]quinolizinium as a Multicolor NIR Probe for the Fluorimetric Detection of Intracellular Nucleic Acids and Proteins. ChemPhotoChem 2021;5:1079-88. [DOI: 10.1002/cptc.202100148] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Li B, Niu S, Geng H, Yang C, Zhao C. Berberine Attenuates Neonatal Sepsis in Mice By Inhibiting FOXA1 and NF-κB Signal Transduction Via the Induction of MiR-132-3p. Inflammation 2021. [PMID: 34523052 DOI: 10.1007/s10753-021-01510-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Cole LK, Zhang M, Chen L, Sparagna GC, Vandel M, Xiang B, Dolinsky VW, Hatch GM. Supplemental Berberine in a High-Fat Diet Reduces Adiposity and Cardiac Dysfunction in Offspring of Mouse Dams with Gestational Diabetes Mellitus. J Nutr 2021;151:892-901. [PMID: 33484149 DOI: 10.1093/jn/nxaa408] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Zhang Y, Wang X, Lu B, Gao Y, Zhang Y, Li Y, Niu H, Fan L, Pang Z, Qiao Y. Functional and binding studies of gallic acid showing platelet aggregation inhibitory effect as a thrombin inhibitor. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.09.001] [Reference Citation Analysis]
51 Xue F, Li X, Qin L, Liu X, Li C, Adhikari B. Anti-aging properties of phytoconstituents and phyto-nanoemulsions and their application in managing aging-related diseases. Adv Drug Deliv Rev 2021;176:113886. [PMID: 34314783 DOI: 10.1016/j.addr.2021.113886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Chen HW, Zhang GZ, Liu MQ, Zhang LJ, Kang JH, Wang ZH, Liu WZ, Lin AX, Kang XW. Natural Products of Pharmacology and Mechanisms in Nucleus Pulposus Cells and Intervertebral Disc Degeneration. Evid Based Complement Alternat Med 2021;2021:9963677. [PMID: 34394398 DOI: 10.1155/2021/9963677] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
53 Patel P. A bird's eye view on a therapeutically ‘wonder molecule’: Berberine. Phytomedicine Plus 2021;1:100070. [DOI: 10.1016/j.phyplu.2021.100070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Tang M, Yuan D, Liao P. Berberine improves intestinal barrier function and reduces inflammation, immunosuppression, and oxidative stress by regulating the NF-κB/MAPK signaling pathway in deoxynivalenol-challenged piglets. Environ Pollut 2021;289:117865. [PMID: 34358871 DOI: 10.1016/j.envpol.2021.117865] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
55 Geetha RG, Ramachandran S. Recent Advances in the Anti-Inflammatory Activity of Plant-Derived Alkaloid Rhynchophylline in Neurological and Cardiovascular Diseases. Pharmaceutics 2021;13:1170. [PMID: 34452133 DOI: 10.3390/pharmaceutics13081170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Wu Y, Chen Q, Wen B, Wu N, He B, Chen J. Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress. Front Pharmacol 2021;12:640758. [PMID: 34349640 DOI: 10.3389/fphar.2021.640758] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
57 Sun Q, He M, Zhang M, Zeng S, Chen L, Zhao H, Yang H, Liu M, Ren S, Xu H. Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery. Front Pharmacol 2021;12:685002. [PMID: 34276374 DOI: 10.3389/fphar.2021.685002] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
58 Wu C, Zhao Y, Zhang Y, Yang Y, Su W, Yang Y, Sun L, Zhang F, Yu J, Wang Y, Guo P, Zhu B, Wu S. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
59 Kovács Z, Brunner B, Ari C. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases. Nutrients 2021;13:2197. [PMID: 34206738 DOI: 10.3390/nu13072197] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
60 Zhang W, Chen L, Xiong Y, Panayi AC, Abududilibaier A, Hu Y, Yu C, Zhou W, Sun Y, Liu M, Xue H, Hu L, Yan C, Xie X, Lin Z, Cao F, Mi B, Liu G. Antioxidant Therapy and Antioxidant-Related Bionanomaterials in Diabetic Wound Healing. Front Bioeng Biotechnol 2021;9:707479. [PMID: 34249895 DOI: 10.3389/fbioe.2021.707479] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
61 Wei R, Han C, He F, Xiong X, Ye F, Liu H, Li L, Xu H, Wei S, Zeng X. Role of forkhead box protein O1 and insulin on cell proliferation mediated by sirtuin 1 in goose primary hepatocytes. Journal of Applied Poultry Research 2021;30:100144. [DOI: 10.1016/j.japr.2021.100144] [Reference Citation Analysis]
62 Khashayar A, Bahari Z, Elliyeh M, Ghasemi M. Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus. Rev Bras Farmacogn 2021;31:272-81. [DOI: 10.1007/s43450-021-00159-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
63 Choudhary N, Khatik GL, Sharma R, Khurana N, Lobo R, Bhatt S, Tewari D, Suttee A. Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies. 3 Biotech 2021;11:309. [PMID: 34194901 DOI: 10.1007/s13205-021-02811-x] [Reference Citation Analysis]
64 Šudomová M, Berchová-Bímová K, Marzocco S, Liskova A, Kubatka P, Hassan STS. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 2021;13:1014. [PMID: 34071559 DOI: 10.3390/v13061014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
65 Chen C, Lin Q, Zhu XY, Xia J, Mao T, Chi T, Wan J, Lu JJ, Li Y, Cui J, Liu J, Cui XY, Zhang J, Zhou K, Li D. Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis. Front Cardiovasc Med 2021;8:646306. [PMID: 34124190 DOI: 10.3389/fcvm.2021.646306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Wickhorst PJ, Blachnik M, Lagumdzija D, Ihmels H. Synthesis of 10-O-aryl-substituted berberine derivatives by Chan-Evans-Lam coupling and investigation of their DNA-binding properties. Beilstein J Org Chem 2021;17:991-1000. [PMID: 34025807 DOI: 10.3762/bjoc.17.81] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Majnooni MB, Fakhri S, Bahrami G, Naseri M, Farzaei MH, Echeverría J. Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms. Evid Based Complement Alternat Med 2021;2021:6632623. [PMID: 34104202 DOI: 10.1155/2021/6632623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
68 Villarroel-Vicente C, Gutiérrez-Palomo S, Ferri J, Cortes D, Cabedo N. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview. Eur J Med Chem 2021;221:113535. [PMID: 33992930 DOI: 10.1016/j.ejmech.2021.113535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
69 Wickhorst PJ, Ihmels H. Berberrubine Phosphate: A Selective Fluorescent Probe for Quadruplex DNA. Molecules 2021;26:2566. [PMID: 33924894 DOI: 10.3390/molecules26092566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Tewari D, Bawari S, Sharma S, DeLiberto LK, Bishayee A. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy. Pharmacol Ther 2021;227:107876. [PMID: 33930452 DOI: 10.1016/j.pharmthera.2021.107876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
71 Guo J, Chen W, Bao B, Zhang D, Pan J, Zhang M. Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms. Bioengineered 2021;12:1324-37. [PMID: 33896366 DOI: 10.1080/21655979.2021.1915671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Xia Y, Chen S, Cui J, Wang Y, Liu X, Shen Y, Gong L, Jiang X, Wang W, Zhu Y, Sun S, Li J, Zou Y, Shi B. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochem Pharmacol 2021;188:114575. [PMID: 33887260 DOI: 10.1016/j.bcp.2021.114575] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
73 Li X, Su C, Jiang Z, Yang Y, Zhang Y, Yang M, Zhang X, Du Y, Zhang J, Wang L, Jiang J, Hong B. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. NPJ Biofilms Microbiomes 2021;7:36. [PMID: 33863898 DOI: 10.1038/s41522-021-00205-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
74 Liu S, Xiao P, Kuang Y, Hao J, Huang T, Liu E. Flavonoids from sea buckthorn: A review on phytochemistry, pharmacokinetics and role in metabolic diseases. J Food Biochem 2021;45:e13724. [PMID: 33856060 DOI: 10.1111/jfbc.13724] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
75 Dong C, Yu J, Yang Y, Zhang F, Su W, Fan Q, Wu C, Wu S. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomed Pharmacother 2021;139:111595. [PMID: 33862492 DOI: 10.1016/j.biopha.2021.111595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Li QP, Dou YX, Huang ZW, Chen HB, Li YC, Chen JN, Liu YH, Huang XQ, Zeng HF, Yang XB, Su ZR, Xie JH. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. Phytomedicine 2021;85:153550. [PMID: 33831691 DOI: 10.1016/j.phymed.2021.153550] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
77 Cai Y, Xin Q, Lu J, Miao Y, Lin Q, Cong W, Chen K. A New Therapeutic Candidate for Cardiovascular Diseases: Berberine. Front Pharmacol 2021;12:631100. [PMID: 33815112 DOI: 10.3389/fphar.2021.631100] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
78 An YW, Jin HT, Yuan B, Wang JC, Wang C, Liu HQ. Research progress of berberine mediated photodynamic therapy. Oncol Lett 2021;21:359. [PMID: 33747216 DOI: 10.3892/ol.2021.12620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, Kamato D, Sahebkar A, Wu W, Weng J, Xu S. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics 2021;11:4502-15. [PMID: 33754074 DOI: 10.7150/thno.54498] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 17.0] [Reference Citation Analysis]
80 Zhao R, Wang B, Wang D, Wu B, Ji P, Tan D. Oxyberberine Prevented Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Mitophagy. Oxid Med Cell Longev 2021;2021:6675264. [PMID: 33728026 DOI: 10.1155/2021/6675264] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
81 Moszak M, Szulińska M, Walczak-Gałęzewska M, Bogdański P. Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. Int J Environ Res Public Health 2021;18:1616. [PMID: 33567710 DOI: 10.3390/ijerph18041616] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Wang YY, Yan Q, Huang ZT, Zou Q, Li J, Yuan MH, Wu LQ, Cai ZY. Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling. J Alzheimers Dis 2021;79:833-44. [PMID: 33361598 DOI: 10.3233/JAD-200995] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
83 Zhang S, Li L, Chen W, Xu S, Feng X, Zhang L. Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res 2021;35:2945-67. [PMID: 33368763 DOI: 10.1002/ptr.7002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
84 Emamat H, Asadian S, Zahedmehr A, Ghanavati M, Nasrollahzadeh J. The effect of barberry (Berberis vulgaris) consumption on flow-mediated dilation and inflammatory biomarkers in patients with hypertension: A randomized controlled trial. Phytother Res 2020. [PMID: 33350540 DOI: 10.1002/ptr.7000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
86 Liu Y, Liu X, Zhang N, Yin M, Dong J, Zeng Q, Mao G, Song D, Liu L, Deng H. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B 2020;10:2299-312. [PMID: 33354502 DOI: 10.1016/j.apsb.2020.06.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
87 Chen X, Jiang X, Cheng C, Chen J, Huang S, Xu M, Liu S. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway. Cardiovasc Drugs Ther 2020;34:463-73. [PMID: 32394178 DOI: 10.1007/s10557-020-06977-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Silva VR, Neves SP, Santos LS, Dias RB, Bezerra DP. Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy. Cancers (Basel) 2020;12:E3461. [PMID: 33233671 DOI: 10.3390/cancers12113461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
89 Xiang XY, Liu T, Wu Y, Jiang XS, He JL, Chen XM, Du XG. Berberine alleviates palmitic acid‑induced podocyte apoptosis by reducing reactive oxygen species‑mediated endoplasmic reticulum stress. Mol Med Rep 2021;23:3. [PMID: 33179098 DOI: 10.3892/mmr.2020.11641] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
90 Och A, Podgórski R, Nowak R. Biological Activity of Berberine-A Summary Update. Toxins (Basel) 2020;12:E713. [PMID: 33198257 DOI: 10.3390/toxins12110713] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
91 Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q, Du H, Xu T, Jiang G, Fan G. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother 2021;133:110984. [PMID: 33186794 DOI: 10.1016/j.biopha.2020.110984] [Cited by in Crossref: 12] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
92 Malekinezhad P, Ellestad LE, Afzali N, Farhangfar SH, Omidi A, Mohammadi A. Evaluation of berberine efficacy in reducing the effects of aflatoxin B1 and ochratoxin A added to male broiler rations. Poult Sci 2021;100:797-809. [PMID: 33518134 DOI: 10.1016/j.psj.2020.10.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
93 Cheng Y, Ji Y, Tong J. Triple stimuli-responsive supramolecular nanoassembly with mitochondrial targetability for chemophotothermal therapy. Journal of Controlled Release 2020;327:35-49. [DOI: 10.1016/j.jconrel.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
94 Ashrafizadeh M, Najafi M, Mohammadinejad R, Farkhondeh T, Samarghandian S. Berberine Administration in Treatment of Colitis: A Review. Curr Drug Targets 2020;21:1385-93. [PMID: 32564751 DOI: 10.2174/1389450121666200621193758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
95 Wang Y, Du P, Jiang D. Berberine functions as a negative regulator in lipopolysaccharide -induced sepsis by suppressing NF-κB and IL-6 mediated STAT3 activation. Pathog Dis 2020;78:ftaa047. [PMID: 32857851 DOI: 10.1093/femspd/ftaa047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Xue JJ, Jiang CY, Zou DL, Li BJ, Lu JC, Li DH, Lin B, Li ZL, Hua HM. Baicalensines A and B, Two Isoquinoline Alkaloids from the Roots of Thalictrum baicalense. Org Lett 2020;22:7439-42. [PMID: 32886519 DOI: 10.1021/acs.orglett.0c02444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
97 Yang C, Zhang W, Dong X, Fu C, Yuan J, Xu M, Liang Z, Qiu C, Xu C. A natural product solution to aging and aging-associated diseases. Pharmacol Ther 2020;216:107673. [PMID: 32926934 DOI: 10.1016/j.pharmthera.2020.107673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
98 Wu X, Yu H, Zhou H, Li Z, Huang H, Xiao F, Xu S, Yang Y. Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway. J Cell Mol Med 2020;24:11960-71. [PMID: 32914567 DOI: 10.1111/jcmm.15818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
99 Sharif H, Akash MSH, Rehman K, Irshad K, Imran I. Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant-based bioactive compounds. J Food Biochem 2020;44:e13449. [PMID: 32851658 DOI: 10.1111/jfbc.13449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
100 Wang L, Deng L, Lin N, Shi Y, Chen J, Zhou Y, Chen D, Liu S, Li C. Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI/ERS and MAPK pathways. Life Sci 2020;259:118253. [PMID: 32795536 DOI: 10.1016/j.lfs.2020.118253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
101 Tomczyk MM, Dolinsky VW. The Cardiac Lipidome in Models of Cardiovascular Disease. Metabolites 2020;10:E254. [PMID: 32560541 DOI: 10.3390/metabo10060254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
102 Zych M, Wojnar W, Kielanowska M, Folwarczna J, Kaczmarczyk-Sedlak I. Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo-A Preliminary Study. Int J Mol Sci 2020;21:E4278. [PMID: 32560082 DOI: 10.3390/ijms21124278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
103 Abdykerimova S, Sakipova Z, Nakonieczna S, Koch W, Biernasiuk A, Grabarska A, Malm A, Kozhanova K, Kukula-Koch W. Superior Antioxidant Capacity of Berberis iliensis-HPLC-Q-TOF-MS Based Phytochemical Studies and Spectrophotometric Determinations. Antioxidants (Basel) 2020;9:E504. [PMID: 32526940 DOI: 10.3390/antiox9060504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
104 Ding Z, Wang X, Liu S, Zhou S, Kore RA, Mu S, Deng X, Fan Y, Mehta JL. NLRP3 inflammasome via IL-1β regulates PCSK9 secretion. Theranostics 2020;10:7100-10. [DOI: 10.7150/thno.45939] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
105 Liu J, Liu P, Xu T, Chen Z, Kong H, Chu W, Wang Y, Liu Y. Berberine Induces Autophagic Cell Death in Acute Lymphoblastic Leukemia by Inactivating AKT/mTORC1 Signaling. Drug Des Devel Ther 2020;14:1813-23. [PMID: 32494123 DOI: 10.2147/DDDT.S239247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
106 Cui CJ, Jin JL, Guo LN, Sun J, Wu NQ, Guo YL, Liu G, Dong Q, Li JJ. Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a. J Transl Med 2020;18:195. [PMID: 32398139 DOI: 10.1186/s12967-020-02362-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
107 Deng M, Su D, Xu S, Little PJ, Feng X, Tang L, Shen A. Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function. Front Pharmacol 2020;11:635. [PMID: 32457625 DOI: 10.3389/fphar.2020.00635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
108 Hallajzadeh J, Maleki Dana P, Mobini M, Asemi Z, Mansournia MA, Sharifi M, Yousefi B. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer. Med Oncol 2020;37:49. [PMID: 32303850 DOI: 10.1007/s12032-020-01367-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
109 Song X, Zhao Y, Wang S, Wang Y, Chen Q, Zhao H, Wang H, Tian S, Yu H, Wu Z. Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling. Front Pharmacol 2020;11:383. [PMID: 32317965 DOI: 10.3389/fphar.2020.00383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Doan HV, Hoseinifar SH, Jaturasitha S, Dawood MA, Harikrishnan R. The effects of berberine powder supplementation on growth performance, skin mucus immune response, serum immunity, and disease resistance of Nile tilapia (Oreochromis niloticus) fingerlings. Aquaculture 2020;520:734927. [DOI: 10.1016/j.aquaculture.2020.734927] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
111 Annunziata G, Jiménez-García M, Capó X, Moranta D, Arnone A, Tenore GC, Sureda A, Tejada S. Microencapsulation as a tool to counteract the typical low bioavailability of polyphenols in the management of diabetes.Food Chem Toxicol. 2020;139:111248. [PMID: 32156568 DOI: 10.1016/j.fct.2020.111248] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
112 Wultańska D, Piotrowski M, Pituch H. The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile. Eur J Clin Microbiol Infect Dis. 2020;39:1391-1399. [PMID: 32140903 DOI: 10.1007/s10096-020-03857-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
113 Abo Zeid AA, Rowida Raafat I, Ahmed AG. Berberine alleviates monosodium glutamate induced postnatal metabolic disorders associated vascular endothelial dysfunction in newborn rats: possible role of matrix metalloproteinase-1. Arch Physiol Biochem 2020;:1-12. [PMID: 32072839 DOI: 10.1080/13813455.2020.1729815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Peng Z, Zhan H, Shao Y, Xiong Y, Zeng L, Zhang C, Liu Z, Huang Z, Su H, Yang Z. 13-Methylberberine improves endothelial dysfunction by inhibiting NLRP3 inflammasome activation via autophagy induction in human umbilical vein endothelial cells. Chin Med 2020;15:8. [PMID: 31993073 DOI: 10.1186/s13020-020-0286-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
115 Wang FX, Li HY, Li YQ, Kong LD. Can Medicinal Plants and Bioactive Compounds Combat Lipid Peroxidation Product 4-HNE-Induced Deleterious Effects? Biomolecules 2020;10:E146. [PMID: 31963301 DOI: 10.3390/biom10010146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Wang D, Huang J, Gui T, Yang Y, Feng T, Tzvetkov NT, Xu T, Gai Z, Zhou Y, Zhang J, Atanasov AG. SR-BI as a target of natural products and its significance in cancer. Semin Cancer Biol 2020:S1044-579X(19)30425-0. [PMID: 31935456 DOI: 10.1016/j.semcancer.2019.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
117 Hu S, Zhao R, Liu Y, Chen J, Zheng Z, Wang S. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers. Biomed Res Int 2019;2019:6831520. [PMID: 31950049 DOI: 10.1155/2019/6831520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
118 Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung AWK, Xu S, Atanasov AG. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products. Pharmacol Rev 2019;71:596-670. [PMID: 31554644 DOI: 10.1124/pr.118.017178] [Cited by in Crossref: 36] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
119 Šudomová M, Shariati MA, Echeverría J, Berindan-Neagoe I, Nabavi SM, Hassan STS. A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Mar Drugs 2019;17:E641. [PMID: 31739453 DOI: 10.3390/md17110641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
120 Wang K, Chen Q, Wu N, Li Y, Zhang R, Wang J, Gong D, Zou X, Liu C, Chen J. Berberine Ameliorates Spatial Learning Memory Impairment and Modulates Cholinergic Anti-Inflammatory Pathway in Diabetic Rats. Front Pharmacol 2019;10:1003. [PMID: 31551793 DOI: 10.3389/fphar.2019.01003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
121 Feng X, Zhang L, Xu S, Shen AZ. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review. Prog Lipid Res 2020;77:101006. [PMID: 31499095 DOI: 10.1016/j.plipres.2019.101006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
122 Yao M, Fan X, Yuan B, Takagi N, Liu S, Han X, Ren J, Liu J. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern Med 2019;19:216. [PMID: 31412862 DOI: 10.1186/s12906-019-2615-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 15.3] [Reference Citation Analysis]
123 Han XJ, Li H, Liu CB, Luo ZR, Wang QL, Mou FF, Guo HD. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment. Life Sci 2019;233:116740. [PMID: 31398416 DOI: 10.1016/j.lfs.2019.116740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
124 Wang J, Jin D. Retracted Article: Berberine alleviates amyloid beta-induced injury in Alzheimer's disease by miR-107/ZNF217. RSC Adv 2019;9:25232-9. [DOI: 10.1039/c9ra04500g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]